Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SEQUENTIAL CHEMOTHERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 98 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sievers, EL
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

      EXPERT OPINION ON BIOLOGICAL THERAPY
    2. Stein, RS; Greer, JP; Goodman, S; Brandt, SJ; Morgan, DS; Macon, WR; McCurley, TL
      Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    3. Brugnatelli, S; Riccardi, A; Danova, M; Pugliese, P; Tinelli, C; Luchena, G; Bernardo, A; Giardina, G; Fava, S; Montanari, G; Pedrotti, C; Poli, AM
      Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: A phase II study

      ONCOLOGY REPORTS
    4. Voog, E; Le, QL; Philip, I; Benetaib, B; Michallet, M; Fiere, D; Thomas, X
      Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone

      ANNALS OF HEMATOLOGY
    5. Bosly, A; Haioun, C; Gisselbrecht, C; Reyes, F; Coiffier, B
      High-dose treatment with autologous stem cell transplantation versus sequential chemotherapy: the GELA experience

      EUROPEAN JOURNAL OF HAEMATOLOGY
    6. Tarella, C; Zallio, F; Caracciolo, D; Cuttica, A; Corradini, P; Gavarotti, P; Ladetto, M; Podio, V; Sargiotto, A; Rossi, G; Gianni, AM; Pileri, A
      High-dose mitoxantrone plus melphalan (MITO/L-PAM) as conditioning regimensupported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity

      LEUKEMIA
    7. van Besien, K; Kelta, M; Bahaguna, P
      Primary mediastinal B-cell lymphoma: A review of pathology and management

      JOURNAL OF CLINICAL ONCOLOGY
    8. Sievers, EL; Larson, RA; Stadtmauer, EA; Estey, E; Lowenberg, B; Dombret, H; Karanes, C; Theobald, M; Bennett, JM; Sherman, ML; Berger, MS; Eten, CB; Loken, MR; van Dongen, JJM; Bernstein, ID; Appelbaum, FR
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

      JOURNAL OF CLINICAL ONCOLOGY
    9. Strother, D; Ashley, D; Kellie, SJ; Patel, A; Jones-Wallace, D; Thompson, S; Heideman, R; Benaim, E; Krance, R; Bowman, L; Gajjar, A
      Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: Resultsof a collaborative study

      JOURNAL OF CLINICAL ONCOLOGY
    10. Serrone, L; Zeuli, M; Papaldo, P; Nardoni, C; Pacetti, U; Cognetti, F
      Ifosfamide and epirubicin combination in untreated sarcomas: Two treatmentschedules

      ONKOLOGIE
    11. Serrone, L; Zeuli, M; Gamucci, T; Nardi, M; Cognetti, F
      A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissuesarcomas; a novel sequential schedule

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    12. Papadopoulos, KP; Noguera-Irizarry, W; Hesdorffer, CS
      Tandem transplantation in lymphoma

      BONE MARROW TRANSPLANTATION
    13. Schrama, JG; Baars, JW; Holtkamp, MJ; Schornagel, JH; Beijnen, JH; Rodenhuis, S
      Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer

      BONE MARROW TRANSPLANTATION
    14. Salar, A; Sierra, J; Gandarillas, M; Caballero, MD; Manin, J; Lahuerta, JJ; Garcia-Conde, J; Arranz, R; Leon, A; Zuazu, J; Garcia-Larana, J; Lopez-Guillermo, A; Sanz, MA; Granena, A; Garcia, JC; Conde, E
      Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

      BONE MARROW TRANSPLANTATION
    15. Edelman, MJ; Gandara, DR; Lau, DHM; Lara, P; Lauder, IJ; Tracy, D
      Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma - Carboplatin and gemcitabine followed by paclitaxel

      CANCER
    16. Viens, P; Maraninchi, D
      High-dose chemotherapy with hematopoietic stem-cell support in breast cancer

      BULLETIN DU CANCER
    17. Riccardi, A; Pugliese, P; Danova, M; Brugnatelli, S; Grasso, D; Giordano, M; Bernardo, G; Giardina, G; Fava, S; Montanari, G; Pedrotti, C; Trotti, G; Rinaldi, E; Poli, M; Tinelli, C
      A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PVBC 97/01)

      BRITISH JOURNAL OF CANCER
    18. Cascinu, S; Graziano, F; Barni, S; Labianca, R; Comella, G; Casaretti, R; Frontini, L; Catalano, V; Baldelli, AM; Catalano, G
      A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer

      BRITISH JOURNAL OF CANCER
    19. Hartmann, JT; von Vangerow, A; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation

      BRITISH JOURNAL OF CANCER
    20. Kluin-Nelemans, HC; Zagonel, V; Anastasopoulou, A; Bron, D; Roozendaal, KJ; Noordijk, EM; Musson, H; Teodorovic, I; Maes, B; Carbone, A; Carde, P; Thomas, J
      Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: Randomized phase III EORTC study

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    21. Hu, WW; Negrin, RS; Stockerl-Goldstein, K; Johnston, LJ; Shizuru, JA; Wong, RM; Chao, NJ; Long, GD; Feiner, RH; Blume, KG
      Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    22. Ferra, C; Berlanga, JJ; Gallardo, D; Ancin, I; Marin, D; Gonzalez, JR; Peris, J; Munoz, J; Sarra, J; Granena, A
      Mitoxantrone, etoposide, carboplatinum and ara-C combination therapy (Meca) in refractory and relapsed acute leukemia

      LEUKEMIA & LYMPHOMA
    23. Ballestrero, A; Clavio, M; Ferrando, F; Gonella, R; Garuti, A; Sessarego, M; Ghio, R; Gobbi, M; Patrone, F
      High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma

      INTERNATIONAL JOURNAL OF ONCOLOGY
    24. Gupta, S; Kumar, L; Raju, GMK; Kochupillai, V; Shukla, DK
      Autologous bone marrow/stem cell transplantation: Initial experience at a north Indian referral centre

      NATIONAL MEDICAL JOURNAL OF INDIA
    25. Haynes, AP
      What is the role of high-dose therapy in the management of lymphoma?

      CLINICAL ONCOLOGY
    26. Poole, CJ; Perren, T; Burton, A; Jordan, SD; Jenkins, AH; Mould, JJ; Spooner, DA; Luesley, D; Chan, KK; Sturman, S; Earl, HM
      Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovariancancer

      ANNALS OF ONCOLOGY
    27. Cerny, T; Betticher, D
      Role of high-dose therapy in diffuse large B-cell lymphoma

      ANNALS OF ONCOLOGY
    28. Fisher, RI
      Diffuse large-cell lymphoma

      ANNALS OF ONCOLOGY
    29. Hauke, RJ; Armitage, JO
      A new approach to non-Hodgkin's lymphoma

      INTERNAL MEDICINE
    30. Dumontet, C; Thieblemont, C; Espinouse, D; Bouafia, F; Hequet, O; Salles, G; Coiffier, B
      A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors

      LEUKEMIA
    31. Tilly, H; Mounier, N; Lederlin, P; Briere, J; Dupriez, B; Sebban, C; Bosly, A; Biron, P; Nouvel, C; Herbrecht, R; Bordessoule, D; Coiffier, B
      Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: The LNH87-1 study

      JOURNAL OF CLINICAL ONCOLOGY
    32. Fanin, R; Sperotto, A; De Elvira, CR; Zaja, F; Stocchi, R; Geromin, A; Cerno, M; Patriarca, F; Canelles, MF; Damiani, D; Baccarani, M
      A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission onoutcome

      HAEMATOLOGICA
    33. Palumbo, A; Triolo, S; Baldini, L; Callea, V; Capaldi, A; De Stefano, V; Grasso, M; Liberati, M; Lotesoriere, C; Marceno, R; Marmont, F; Musto, P; Petrucci, MT; Spriano, M; Pileri, A; Boccadoro, M
      Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients

      HAEMATOLOGICA
    34. Greinix, HT
      Autologous stem-cell transplantation in Hodgkin's and non-Hodgkin's lymphoma

      ACTA MEDICA AUSTRIACA
    35. Andersson, PO; Brune, M; Ekman, T
      Remission inversion and no transplant-related mortality - A single centre experience of autologous stem cell transplantation in malignant lymphoma

      ACTA ONCOLOGICA
    36. Bouabdallah, R; Coso, D; Costello, R; Bardou, VJ; Blaise, D; Xerri, L; Sainty, D; Maraninchi, D; Gastaut, JA
      Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center

      BONE MARROW TRANSPLANTATION
    37. Genre, D; Viens, P; Gravis, G; Bertucci, F; Cowen, D; Novakovitch, G; Dermeche, S; Chabannon, C; Oziel-Taieb, S; Camerlo, J; Houvenaeghel, G; Jacquemier, J; Maraninchi, D
      Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study

      ANTICANCER RESEARCH
    38. Thomas, X; Cambier, N; Taksin, AL; Reman, O; Vekhoff, A; Pautas, C; Leblond, V; Soler-Michel, P; Ecstein-Fraisse, E; Archimbaud, E
      Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia

      LEUKEMIA RESEARCH
    39. Fisher, RI
      Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma

      SEMINARS IN ONCOLOGY
    40. Deconinck, E; Lamy, T; Foussard, C; Gaillard, F; Delwail, V; Colombat, P; Casassus, P; Lemevel, A; Brion, A; Milpied, N
      Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial

      BRITISH JOURNAL OF HAEMATOLOGY
    41. Sweetenham, JW
      Economics of stem cell transplantation for lymphoma: counting the cost of living

      BRITISH JOURNAL OF CANCER
    42. Chabannon, C; Novakovitch, G; Blache, JL; Olivero, S; Camerlo, J; Genre, D; Maraninchi, D; Viens, P
      The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell (R) technology

      HEMATOLOGY AND CELL THERAPY
    43. Hu, WW; Long, GD; Stockerl-Goldstein, KE; Johnston, LJ; Chao, NJ; Negrin, RS; Blume, KG
      A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer

      CLINICAL CANCER RESEARCH
    44. Tarella, C; Zallio, F; Caracciolo, D; Cherasco, C; Bondesan, P; Gavarotti, P; Corradini, P; Tassi, V; Pileri, A
      Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients

      STEM CELLS
    45. Chabannon, C; Blache, JL; Sielleur, I; Douville, J; Faucher, C; Gravis, G; Arnoulet, C; Oziel-Taieb, S; Blaise, D; Novakovitch, G; Camerlo, J; Chabbert, I; Genre, D; Appel, M; Armstrong, D; Maraninchi, D; Viens, P
      Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-dosesof cyclophosphamide

      INTERNATIONAL JOURNAL OF ONCOLOGY
    46. Santoro, A; Balzarotti, M; Castagna, L
      Intensified CHOP in non-Hodgkin's lymphoma: What we know and what we need to know

      ANNALS OF ONCOLOGY
    47. Santoro, A; Balzarotti, M; Tondini, C; Zanini, M; Giardini, R; Latteri, F; Rampinelli, I; Bufalino, R
      Dose-escalation of CHOP in non-Hodgkin's lymphoma

      ANNALS OF ONCOLOGY
    48. Culine, S; Fabbro, M; Ychou, M; Romieu, G; Cupissol, D; Pujol, H
      Chemotherapy in carcinomas of unknown primary site: A high-dose intensity policy

      ANNALS OF ONCOLOGY
    49. Cortelazzo, S; Rossi, A; Bellavita, P; Oldani, E; Viero, P; Buelli, M; Rambaldi, A; Barbui, T
      Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI)

      ANNALS OF ONCOLOGY
    50. Shipp, MA; Abeloff, MD; Antman, KH; Carroll, G; Hagenbeek, A; Loeffler, M; Montserrat, E; Radford, JA; Salles, G; Schmitz, N; Symann, M; Armitage, JO; Coiffier, B; Philip, T
      International Consensus Conference on High-Dose Therapy with HematopoieticStem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report ofjury

      ANNALS OF ONCOLOGY
    51. Winter, JN
      High-dose therapy with stem-cell transplantation in the malignant lymphomas

      ONCOLOGY-NEW YORK
    52. Thomas, X; Fenaux, P; Dombret, H; Delair, S; Dreyfus, F; Tilly, H; Vekhoff, A; Cony-Makhoul, P; Leblond, V; Troussard, X; Cordonnier, C; de Revel, T; Simon, M; Nicolini, F; Stoppa, AM; Janvier, M; Bordessoule, D; Rousselot, P; Ffrench, M; Marie, JP; Archimbaud, E
      Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

      LEUKEMIA
    53. Bouabdallah, R; Stoppa, AM; Rossi, JF; Lepeu, G; Coso, D; Xerri, L; Ladaique, P; Chabannon, C; Blaise, D; Bardou, VJ; Alzieu, C; Gastaut, JA; Maraninchi, D
      Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients

      LEUKEMIA
    54. Shipp, MA; Abeloff, MD; Antman, KH; Carroll, G; Hagenbeek, A; Loeffler, M; Montserrat, E; Radford, JA; Salles, G; Schmitz, N; Symann, M; Armitage, JO; Philip, T; Coiffier, B
      International consensus conference on high-dose therapy with hematopoieticstem cell transplantation in aggressive non-hodgkin's lymphomas: Report ofthe jury

      JOURNAL OF CLINICAL ONCOLOGY
    55. Wandt, H; Birkmann, J; Denzel, T; Schafer, K; Schwab, G; Pilz, D; Egger, H; Both, A; Gallmeier, WM
      Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer

      BONE MARROW TRANSPLANTATION
    56. Ketterer, N; Sonet, A; Dumontet, C; Moullet, I; Thieblemont, C; Espinouse, D; Bouafia, F; Coiffier, B; Salles, G
      Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution

      BONE MARROW TRANSPLANTATION
    57. Balzarotti, M; Grisanti, S; Granzow, K; Saladini, A; Sala, A; Nozza, A; Molteni, A; Passamonti, F; Carlo-Stella, C; Santoro, A; Siena, S
      Ex vivo manipulation of hematopoietic stem cells for transplantation: The potential role of amifostine

      SEMINARS IN ONCOLOGY
    58. Dhedin, N; Giraudier, S; Gaulard, P; Esperou, H; Ifrah, N; Michallet, M; Milpied, N; Rio, B; Cahn, JY; Molina, L; Laporte, JL; Guilhot, F; Kuentz, M
      Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

      BRITISH JOURNAL OF HAEMATOLOGY
    59. Stahel, RA; Jost, LM; Kroner, T; Dommann-Scherrer, C; Maurer, R; Glanzmann, C; Jacky, E; Pichert, G; Pestalozzi, B; Marincek, B; Sauter, C; Honegger, H
      A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission

      BRITISH JOURNAL OF HAEMATOLOGY
    60. Viens, P; Palangie, T; Janvier, M; Fabbro, M; Roche, H; Delozier, T; Labat, JP; Linassier, C; Audhuy, B; Feuilhade, F; Costa, B; Delva, R; Cure, H; Rousseau, F; Guillot, A; Mousseau, M; Ferrero, JM; Bardou, VJ; Jacquemier, J; Pouillart, P
      First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)

      BRITISH JOURNAL OF CANCER
    61. VIENS P; GENRE D; PROTIERE C; GRAVIS G; BERTUCCI F; COWEN D; CAMERLO J; CHABANNON C; NOVAKOVITCH G; CONTE M; FINAUD M; MOATTI JP; MARANINCHI D
      BENEFITS OF GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER STEM-CELL TRANSFUSION IN INTENSIVE SEQUENTIAL CHEMOTHERAPY FOR BREAST-CANCER

      European cytokine network
    62. ODDOU S; VEY N; VIENS P; BARDOU VJ; FAUCHER C; STOPPA AM; CHABANNON C; CAMERLO J; BOUABDALLAH R; GASTAUT JA; MARANINCHI D; BLAISE D
      2ND NEOPLASMS FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS - A REPORT OF 6 CASES IN A COHORT OF 171 PATIENTS FROM A SINGLE INSTITUTION

      Leukemia & lymphoma
    63. Gale, RP; Park, RE; Dubois, R; Bierman, PJ; Fisher, RI; Loh, KK; Peterson, BA; Phillips, GL; Portlock, CS; Rosenblum, D; Armitage, JO
      Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma

      LEUKEMIA & LYMPHOMA
    64. Le Corroller, AG; Moatti, JP
      The economic evaluation of hematopoietic growth factors in high-dose chemotherapy

      ANTI-CANCER DRUGS
    65. KERN W; AUL C; MASCHMEYER G; SCHONROCKNABULSI R; LUDWIG WD; BARTHOLOMAUS A; BETTELHEIM P; WORMANN B; BUCHNER T; HIDDEMANN W
      SUPERIORITY OF HIGH-DOSE OVER INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF PATIENTS WITH HIGH-RISK ACUTE MYELOID-LEUKEMIA - RESULTS OF AN AGE-ADJUSTED PROSPECTIVE RANDOMIZED COMPARISON

      Leukemia
    66. ROWE JM
      WHAT IS THE BEST INDUCTION REGIMEN FOR ACUTE MYELOGENOUS LEUKEMIA

      Leukemia
    67. SANTINI G; SALVAGNO L; LEONI P; CHISESI T; DESOUZA C; SERTOLI MR; RUBAGOTTI A; CONGIU AM; CENTURIONI R; OLIVIERI A; TEDESCHI L; VESPIGNANI M; NATI S; SORACCO M; PORCELLINI A; CONTU A; GUARNACCIA C; PESCOSTA N; MAJOLINO I; SPRIANO M; VIMERCATI R; ROSSI E; ZAMBALDI G; MANGONI L; ENDRIZZI L; SILENI VC; MIGGIANO MC; MARINO G; DAMASIO E; RIZZOLI V
      VACOP-B VERSUS VACOP-B PLUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL BY THE NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP

      Journal of clinical oncology
    68. TARELLA C; CASTELLINO C; LOCATELLI F; CARACCIOLO D; CORRADINI P; FALDA M; NOVARINO A; TASSI V; PILERI A
      G-CSF ADMINISTRATION FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFT IN LYMPHOID MALIGNANCIES - EVIDENCE FOR CLINICAL BENEFITS AND REDUCTION OF TREATMENT COSTS

      Bone marrow transplantation
    69. FANIN R; SILVESTRI F; GEROMIN A; INFANTI L; SPEROTTO A; CERNO M; STOCCHI R; SAVIGNANO C; RINALDI C; DAMIANI D; BACCARANI M
      AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR AGGRESSIVE NON-HODGKINS-LYMPHOMAS IN FIRST COMPLETE OR PARTIAL REMISSION - A RETROSPECTIVE ANALYSIS OF THE OUTCOME OF 52 PATIENTS ACCORDING TO THE AGE-ADJUSTED INTERNATIONAL PROGNOSTIC INDEX

      Bone marrow transplantation
    70. WILLNER J; FLENTJE M; SCHMIDT M; WIRTZ H; HUBER RM; FISCHER R; LANG S
      COMBINED WEEKLY PACLITAXEL AND RADIOTHERAPY OF STAGE-III INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC) - RESULTS OF A DOSE-ESCALATION STUDY

      Strahlentherapie und Onkologie
    71. PAPADIMITRIOU CA; DIMOPOULOS MA; AMPELA C; LOUVROUFERTAKI A; ANAGNOSTOPOULOS A; ATHANASSIADES P; STAMATELOPOULOS S; KERAMOPOULOS A
      SEQUENTIAL ADMINISTRATION OF DOXORUBICIN AND PACLITAXEL FOLLOWED BY CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL COMBINATION (CMF) IN WOMEN WITH METASTATIC BREAST-CANCER

      Oncology
    72. FLEISCHHACK G; HASAN C; GRAF N; MANN G; BODE U
      IDA-FLAG (IDARUBICIN, FLUDARABINE, CYTARABINE, G-CSF), AN EFFECTIVE REMISSION-INDUCTION THERAPY FOR POOR-PROGNOSIS AML OF CHILDHOOD PRIOR TO ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION - EXPERIENCES OF A PHASE-II TRIAL

      British Journal of Haematology
    73. Perey, L; Peters, R; Pampallona, S; Schneider, P; Gross, N; Leyvraz, S
      Extensive phenotypic analysis of CD34 subsets in successive collections ofmobilized peripheral blood progenitors

      BRITISH JOURNAL OF HAEMATOLOGY
    74. THOMAS X; ARCHIMBAUD E
      MITOXANTRONE IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A REVIEW

      HEMATOLOGY AND CELL THERAPY
    75. THOMAS X; ANGLARET B; THIEBAUT A; BELHABRI A; TREILLERITOUET D; FIERE D; ARCHIMBAUD E
      IMPROVEMENT OF PROGNOSIS IN REFRACTORY AND RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA OVER RECENT YEARS - THE ROLE OF ALL-TRANS-RETINOIC ACID THERAPY

      Annals of hematology
    76. KATANO N; TSURUSAWA M; HIROTA T; HORIKOSHI Y; MIMAYA J; YANAI M; TSUJI Y; FUJIMOTO T
      TREATMENT OUTCOME AND PROGNOSTIC FACTORS IN CHILDHOOD ACUTE MYELOBLASTIC-LEUKEMIA - A REPORT FROM THE JAPANESE CHILDRENS CANCER AND LEUKEMIA STUDY-GROUP (CCLSG)

      International journal of hematology
    77. CULINE S; FABBRO M; ASSENS C; YCHOU M; ROMIEU G; KRAMAR A; CUPISSOL D; PINGUET F; PUJOL H
      4-STEP HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH HEMATOPOIETIC PROGENITOR-CELL SUPPORT AS INDUCTION TREATMENT FOR PATIENTS WITH SOLID TUMORS

      Annals of oncology
    78. SHARMA D; KRASNOW SH; DAVIS EB; LUNZER S; HUSSAIN MA; WADLEIGH RG
      SEQUENTIAL CHEMOTHERAPY AND RADIOTHERAPY FOR SQUAMOUS-CELL ESOPHAGEAL-CARCINOMA

      American journal of clinical oncology
    79. CHAN KW; PETROPOULOS D; CHOROSZY M; HERZOG C; JAFFE N; ATER J; KORBLING M
      HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL REINFUSIONIN ADVANCED PEDIATRIC SOLID TUMORS

      Bone marrow transplantation
    80. PALUMBO A; PILERI A; TRIOLO S; OMEDE P; BRUNO B; CIRAVEGNA G; GALLIANO M; FRIERI R; BOCCADORO M
      MULTICYCLIC, DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED BY HEMATOPOIETIC PROGENITORS IN REFRACTORY MYELOMA PATIENTS

      Bone marrow transplantation
    81. TARELLA C; CASTELLINO C; CHERASCO C; BONDESAN P; GIARETTA F; CORRADINI P; CARACCIOLO D; GAVAROTTI P; PILERI A
      PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH PRIMARY REFRACTORY LYMPHOMA OR AT FIRST RELAPSE - COMPARISON WITH PATIENTS AT DIAGNOSIS AND IMPACT ON CLINICAL OUTCOME

      British Journal of Haematology
    82. ROWE JM; TALLMAN MS
      INTENSIFYING INDUCTION THERAPY IN ACUTE MYELOID-LEUKEMIA - HAS A NEW STANDARD OF CARE EMERGED

      Blood
    83. CORRADINI P; ASTOLFI M; CHERASCO C; LADETTO M; VOENA C; CARACCIOLO D; PILERI A; TARELLA C
      MOLECULAR MONITORING OF MINIMAL RESIDUAL DISEASE IN FOLLICULAR AND MANTLE CELL NON-HODGKINS-LYMPHOMAS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL AUTOGRAFTING

      Blood
    84. DUNN CJ; GOA KL
      MITOXANTRONE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND USE IN ACUTE NONLYMPHOBLASTIC LEUKEMIA

      Drugs & aging
    85. GELLER RB
      USE OF CYTOKINES IN THE TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA - A CRITICAL-REVIEW

      Journal of clinical oncology
    86. MARTELLI M; VIGNETTI M; ZINZANI PL; GHERLINZONI F; MELONI G; FIACCHINI M; DESANCTIS V; PAPA G; MARTELLI MF; CALABRESI F; TURA S; MANDELLI F
      HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKINS-LYMPHOMA WITH PARTIAL-RESPONSE TO FRONT-LINE CHEMOTHERAPY - A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY

      Journal of clinical oncology
    87. INFANTI L; SILVESTRI F; FANIN R; SALMASO F; ZAJA F; BARILLARI G; PATRIARCA F; GEROMIN A; CERNO M; DAMIANI D; BACCARANI M
      THE F-MACHOP REGIMEN IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS - A SINGLE-CENTER EXPERIENCE IN 72 PATIENTS

      Haematologica
    88. STEVENS RF
      ACUTE MYELOID-LEUKEMIA

      British Medical Bulletin
    89. TARELLA C; GAVAROTTI P; CARACCIOLO D; CORRADINI P; CHERASCO C; CASTELLINO C; GALLO E; PILERI A
      HEMATOLOGICAL SUPPORT OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY - CLINICAL-EVIDENCE FOR REDUCTION OF TOXICITY AND HIGH RESPONSE RATES IN POOR-RISK LYMPHOMAS

      Annals of oncology
    90. YAMADA K; FURUSAWA S; SAITO K; WAGA K; KOIKE T; ARIMURA H; AOYAGI A; YAMATO H; SAKUMA H; TSUNOGAKE S; YOSHIDA M; AOYAGI M; NAKAMURA Y; ENOKIHARA H; TANAKA K; NAKAZAWA K; SHISHIDO H
      CONCURRENT USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR WITH LOW-DOSECYTOSINE-ARABINOSIDE AND ACLARUBICIN FOR PREVIOUSLY TREATED ACUTE MYELOGENOUS LEUKEMIA - A PILOT-STUDY

      Leukemia
    91. HOLDEN SA; TEICHER BA; AYASH LJ; FREI E
      A PRECLINICAL MODEL FOR SEQUENTIAL HIGH-DOSE CHEMOTHERAPY

      Cancer chemotherapy and pharmacology
    92. THOMAS X; ARCHIMBAUD E
      INFUSIONAL CYTOSINE-ARABINOSIDE ADMINISTR ATION FOR THE TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA

      Bulletin du cancer
    93. ARCHIMBAUD E; THOMAS X; MICHALLET M; JAUBERT J; TRONCY J; GUYOTAT D; FIERE D
      PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA

      Journal of clinical oncology
    94. YAMAGATA N; SHIMAZAKI C; GOTO H; HIRATA T; ASHIHARA E; OKU N; INABA T; FUJITA N; NAKAGAWA M
      IGE PLASMA-CELL LEUKEMIA SUCCESSFULLY TREATED WITH COMBINATION VAD (VINCRISTINE, DOXORUBICIN, DEXAMETHASONE) AND MP (MELPHALAN, PREDNISOLONE) FOLLOWED BY INTERFERON-ALPHA

      American journal of hematology
    95. BRODER LE; SRIDHAR KS; SELAWRY OS; CHARYULU KN; RAO RK; SALDANA MJ; DONNELLY EJ; RAUB WA
      A RANDOMIZED CLINICAL-TRIAL IN BRONCHOGENIC SMALL-CELL CARCINOMA EVALUATING ALTERNATING MAINTENANCE THERAPY OF VINCRISTINE, ADRIAMYCIN, PROCARBAZINE, AND ETOPOSIDE (VAPE) WITH CYCLOPHOSPHAMIDE, CCNU, AND METHOTREXATE (CCM) VERSUS CCM MAINTENANCE ALONE IN COMPLETE RESPONDERS FOLLOWING VAPE INDUCTION AND LATE INTENSIFICATION

      American journal of clinical oncology
    96. WOODS WG; KOBRINSKY N; BUCKLEY J; NEUDORF S; SANDERS J; MILLER L; BARNARD D; BENJAMIN D; DESWARTE J; KALOUSEK D; SHINA D; HAMMOND GD; LANGE BJ
      INTENSIVELY TIMED INDUCTION THERAPY FOLLOWED BY AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE MYELOID-LEUKEMIA OR MYELODYSPLASTIC SYNDROME - A CHILDRENS CANCER GROUP PILOT-STUDY

      Journal of clinical oncology
    97. RIMERMAN RA; PROROK GD; CORDEL KL; SHAHWAN AM; VAUGHAN WP
      IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF INTRACELLULAR DEOXYRIBONUCLEOSIDE TRIPHOSPHATE LEVELS

      Journal of chromatography. Biomedical applications
    98. DHALIWAL HS; ROHATINER AZS; GREGORY W; RICHARDS MA; JOHNSON PWM; WHELAN JS; GALLAGHER CJ; MATTHEWS J; GANESAN TS; BARNETT MJ; WAXMAN JH; STANSFELD AG; WRIGLEY PFM; SLEVIN ML; MALPAS JS; LISTER TA
      COMBINATION CHEMOTHERAPY FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA

      British Journal of Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/11/20 alle ore 05:48:51